Atrial fibrillation better care pathway
Intervention1 paper1 finding
C · W · M · H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.
Labs are independent when their papers share no last author and no institution.
Against: findings that point the other way from most findings on the same outcome.
No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.
Company ties: findings with an author at a company, or from a paper that declares the maker’s interest.
- Humans1
Associations
1All-cause death or major adverse cardiovascular events
downin humans1HR 0.53
1 study
All-cause death or major adverse cardiovascular events
downin humans1HR 0.53
Atrial fibrillation better care pathway lowers the risk of all-cause death or major adverse cardiovascular events in humans (HR: 0.53, 95% CI: 0.38-0.74).
Humansin Asian patients with atrial fibrillationmedian of 364 daysn = 3,468
Adverse Events and ABC Pathway Adherence Across AF Clinical Phenotypes: APHRS-AF Registry Cluster Analysis Study · JACC. Asia · 30 Jul 2026